A consumer group, Public Citizen, described that the producer of the cholesterol reducing medication, Astra Zeneca, earlier registered its application with the Food and Drug Administration to marketplace the drug in June of 2001. The application was deferred because of studies of Crestor fallouts such as kidney damage and muscular tissue weakness which are primaeval signs for rhabdomyolysis during clinical test in patients taking 80mg of the drug per day. Because of these fallouts for Crestor, the medicinal drug will only be distributed in 5, 10, 20 and 40mg strengths. Particular limitations on the distribution of the 40mg strength will also be imposed. Public Citizen controverted the approval because of the so-called side effects of Crestor. Contact your lawyer and file for a Crestor lawsuit if you feel you are having the side effects after taking this medicament.